Patients need a more meaningful role in decisions about the value of medications, a new report from the Global Alliance for Patient Access explains.

Effectively treating rheumatic and musculoskeletal diseases doesn’t just serve patients. It also benefits Europe’s workplaces.

The COVID-19 pandemic has made one point clear for advocates: Health technology assessments across Europe could work better and more efficiently.

Reaching consensus is a challenge for any community, and the global health care community is no exception.

According to new research from the World Health Organization, the treatment and prevention of non-communicable diseases have been “severely disrupted” since the pandemic began.

Los lideres y advocates de pacientes en América Latina están explorando como las políticas inteligentes pueden fomentar la innovación y proteger el acceso de los pacientes durante COVID-19.

Patient advocates across Latin America are exploring how smart policy can encourage innovation and protect patient access during COVID-19.

Last month patient groups and Members of the European Parliament pledged to “leave no-one behind” in their response to the COVID-19 pandemic.

“COVID phobia” has increased the novel coronavirus’ collateral damage by stopping high-risk patients from seeking necessary care.

With the world’s attention on new and re-emerging outbreaks of COVID-19, advocates are working towards policies that ensure care for overshadowed patient groups.